CR9340A - Las 1,3-tiazol-5-carboxamidas utiles como agentes qumioterapeuticos contra el cancer - Google Patents

Las 1,3-tiazol-5-carboxamidas utiles como agentes qumioterapeuticos contra el cancer

Info

Publication number
CR9340A
CR9340A CR9340A CR9340A CR9340A CR 9340 A CR9340 A CR 9340A CR 9340 A CR9340 A CR 9340A CR 9340 A CR9340 A CR 9340A CR 9340 A CR9340 A CR 9340A
Authority
CR
Costa Rica
Prior art keywords
qumiotherapeutic
carboxamids
tiazol
useful
against cancer
Prior art date
Application number
CR9340A
Other languages
English (en)
Inventor
Chih-Yuan Chuang
Philip Wickens
Zhenqiu Hong
Catherine Brennan
Julie A Dixon
Harold C E Kluender
Charles Kreiman
Ellalahewage Kumarasinghe
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of CR9340A publication Critical patent/CR9340A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invencion esta relacionada con los nuevos compuestos de la 1,3-tiazol-5-carboxamida, las composiciones farmaceuticas que contienen tales componentes, y el uso de dichos compuestos o composiciones como agentes quimioterapicos contra el cancer.
CR9340A 2005-03-04 2007-08-27 Las 1,3-tiazol-5-carboxamidas utiles como agentes qumioterapeuticos contra el cancer CR9340A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65898505P 2005-03-04 2005-03-04

Publications (1)

Publication Number Publication Date
CR9340A true CR9340A (es) 2010-04-05

Family

ID=36676308

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9340A CR9340A (es) 2005-03-04 2007-08-27 Las 1,3-tiazol-5-carboxamidas utiles como agentes qumioterapeuticos contra el cancer

Country Status (15)

Country Link
US (1) US20090023753A1 (es)
EP (1) EP1858893A1 (es)
JP (1) JP2008531688A (es)
KR (1) KR20070118100A (es)
CN (1) CN101133054A (es)
AU (1) AU2006221037A1 (es)
BR (1) BRPI0609147A2 (es)
CA (1) CA2600039A1 (es)
CR (1) CR9340A (es)
EA (1) EA200701881A1 (es)
IL (1) IL185518A0 (es)
MA (1) MA29671B1 (es)
MX (1) MX2007010099A (es)
TN (1) TNSN07300A1 (es)
WO (1) WO2006096338A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101932587A (zh) 2007-09-24 2010-12-29 吉宁特有限公司 噻唑并嘧啶pi3k抑制剂化合物及使用方法
KR101051078B1 (ko) 2008-12-05 2011-07-21 한국화학연구원 염증관련 질환치료제용 2,4-이중치환-5-아미노카르보닐-1,3-티아졸 유도체, 그의 제조방법 및 그를 유효성분으로 함유하는 ｓｐｃ 수용체 활성으로 유발되는 염증관련질환 치료제
EP2616451A1 (en) * 2010-09-14 2013-07-24 Merck Sharp & Dohme Corp. Novel thiazol-carboximide derivatives as pdk1 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995162B2 (en) * 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
TWI299664B (en) * 2003-01-06 2008-08-11 Osi Pharm Inc (2-carboxamido)(3-amino)thiophene compounds
DE102004039876A1 (de) * 2004-06-23 2006-01-26 Lanxess Deutschland Gmbh Herstellung von fluorierten 1,3-Benzodioxanen

Also Published As

Publication number Publication date
MA29671B1 (fr) 2008-08-01
BRPI0609147A2 (pt) 2010-02-17
JP2008531688A (ja) 2008-08-14
EP1858893A1 (en) 2007-11-28
IL185518A0 (en) 2008-01-06
US20090023753A1 (en) 2009-01-22
CA2600039A1 (en) 2006-09-14
WO2006096338A1 (en) 2006-09-14
AU2006221037A1 (en) 2006-09-14
TNSN07300A1 (en) 2008-12-31
EA200701881A1 (ru) 2008-02-28
MX2007010099A (es) 2007-10-12
KR20070118100A (ko) 2007-12-13
CN101133054A (zh) 2008-02-27

Similar Documents

Publication Publication Date Title
HN2006019068A (es) "sintesis de (r)-n-metilnaltrexona"
UY30314A1 (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
DOP2006000269A (es) Derivados de 4-amino-pirrolotriazina sustituida útiles para el tratamiento de trastornos hiper-proliferativos y enfermedades asociadas con la angiogénesis
CR9014A (es) Novedosos derivados de heteroarilsulfamida benzofusionados como agentes anticonvulsionantes
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
CR8986A (es) Isoxazoles sustituidos como fungicidas
CU23464B7 (es) (1,8)naftidirin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
GT200500179AA (es) Mezclas sinergistas de agentes de antranilamida para el control de plagas de invertebrados
GT200900027A (es) Compuestos organicos
UY29530A1 (es) Compuestos quimicos
BRPI0411528A (pt) uso de isomalte como prebiótico
CR10304A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
HN2010002478A (es) Derivados de indazol sustituidos con fenilo y benzodioxinilo
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
CR10479A (es) Modulares bencimidazolicos de vr1
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
CR9663A (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
UY28670A1 (es) Arilpirazoles sustituidos
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
GT200600199A (es) Diarilsulfonas sulfonamidas y su uso
HN2003000080A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
PA8667201A1 (es) Nuevos compuestos farmaceuticos
HN2010000330A (es) DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION
CR8288A (es) 6-[ (sustituido) fenil] triazolopirimidinas como agentes anticancer

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)